Track Every Presidential Action. Understand the Impact.

INCREASING MEDICAL MARIJUANA AND CANNABIDIOL RESEARCH

President Donald Trump has issued an order to enhance research on medical marijuana and cannabidiol (CBD) to improve healthcare guidance for patients and doctors. The order directs the Attorney General to expedite the process of rescheduling marijuana from Schedule I to Schedule III under the Controlled Substances Act, acknowledging its accepted medical use. It also instructs collaboration with Congress to refine regulations on hemp-derived cannabinoid products, ensuring safe access to full-spectrum CBD products. The initiative aims to close the knowledge gap on the risks and benefits of these substances, particularly focusing on vulnerable populations. The order underscores the need for real-world evidence in research to better inform standards of care.